Chemomab Therapeutics Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
Chemomab Therapeutics Ltd. has filed 352 SEC EDGAR filings since 07 Nov 2011

SEC filing history

Showing 26-50 of 352 matching filings.

Per page
25
Current page
2
SCHEDULE 13G/A File 005-86953

SCHEDULE 13G/A filing

Filing date
07 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-86953

SCHEDULE 13G filing

Filing date
07 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
25 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-275002

424B5

Filing date
25 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
01 Jul 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-86953

SCHEDULE 13D/A filing

Filing date
23 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
27 May 2025
Reporting date
27 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
15 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
15 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-86953

SCHEDULE 13G/A filing

Filing date
10 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
27 Mar 2025
Reporting date
27 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
20 Mar 2025
Reporting date
20 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
03 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
19 Feb 2025
Reporting date
19 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-255249

EFFECT filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-255249

POS AM

Filing date
02 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
29 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86953

SCHEDULE 13G

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
18 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-275002

424B5

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
14 Nov 2024
Reporting date
14 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38807

6-K

Filing date
11 Oct 2024
Reporting date
11 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

AMENDMENT NO. 4

Filing date
16 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38807

144 filing

Filing date
12 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .